OrthoPediatrics Corp. (KIDS) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2023
Loading P/E history...
KIDS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, OrthoPediatrics Corp. (KIDS) trades at a price-to-earnings ratio of -10.4x, with a stock price of $17.57 and trailing twelve-month earnings per share of $-1.68.
The current P/E is 102% below its 5-year average of 505.3x. Over the past five years, KIDS's P/E has ranged from a low of 119.3x to a high of 1196.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, KIDS trades at a 147% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, KIDS trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our KIDS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
KIDS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $12B | 21.7 | 0.70Best | +423%Best | |
| $16B | 23.5 | - | -20% | |
| $113B | 35.0 | 2.36 | +8% | |
| $548M | 11.5Lowest | - | +14% | |
| $100B | 21.6 | - | +31% | |
| $536B | 38.4 | - | -58% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
KIDS Historical P/E Data (2022–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $43.85 | $0.09 | 487.2x | -4% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $44.29 | $0.20 | 218.0x | -57% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $39.73 | $0.03 | 1196.7x | +137% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $46.14 | $0.39 | 119.3x | -76% |
Average P/E for displayed period: 505.3x
See KIDS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KIDS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KIDS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKIDS — Frequently Asked Questions
Quick answers to the most common questions about buying KIDS stock.
Is KIDS stock overvalued or undervalued?
KIDS trades at -10.4x P/E, below its 5-year average of 505.3x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does KIDS's valuation compare to peers?
OrthoPediatrics Corp. P/E of -10.4x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is KIDS's PEG ratio?
KIDS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2023.